Showing all 3 results
Acebrophylline (SR) ,Montelukast & Fexofenadine Tablets
FreeProduct Composition & Strength
We supply this product as a Sustained-Release, Film-Coated Tablet, engineered to provide a steady-state therapeutic concentration over a full 24-hour cycle.
Active Ingredient Strength Primary Clinical Function Acebrophylline (SR) USP/BP 200 mg The Broncho-Mucolytic: Relaxes airways and thins mucus for 24-hour breathing comfort. Montelukast (as Sodium) USP/BP 10 mg The LTRA: Prevents chronic inflammation and asthma triggers in the lungs. Fexofenadine HCl USP/BP 120 mg The Antihistamine: Provides non-sedating relief from upper respiratory allergic symptoms. ACEBROPHYLLINE (SR)+ MONTELUKAST TABLETS
FreeProduct Composition & Strength
We supply this product as a Sustained-Release, Film-Coated Tablet, engineered to provide synchronized therapeutic levels with convenient once-daily dosing.
Active Ingredient Strength Primary Clinical Function Acebrophylline (SR) USP/BP 200 mg The Airway Opener: Provides 24-hour bronchodilation and thins thick mucus. Montelukast (as Sodium) USP/BP 10 mg The Inflammation Blocker: Prevents asthma triggers and reduces lung swelling. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide a smooth plasma curve, minimizing heart palpitations. Acebrophylline Tablets
FreeProduct Composition & Strength
We supply this product as both an Immediate-Release Tablet for acute management and a Sustained-Release (SR) Tablet for 24-hour protection.
Active Ingredient Strength Primary Clinical Function Acebrophylline USP/BP 100 mg The Standard Relief Unit: Taken twice daily to manage active symptoms of bronchitis and asthma. Acebrophylline USP/BP 200 mg SR The 24-Hour Anchor: A sustained-release format that provides consistent airway stability with once-daily dosing. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide a smooth plasma concentration curve, minimizing the risk of “Theophylline-like” side effects.
